Buparvaquone nanostructured lipid carrier development: physicochemical and in vitro leishmanicidal performances
Leishmaniases is a group of diseases caused by parasites of the genus Leishmania. The estimated number of deaths from visceral leishmaniases ranges from 20,000 to 50,000 annually. The most common treatment over the past 60 years has been pentavalent antimonials. Besides the doubtful effectivenes...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | English |
| Published: |
Universidade de São Paulo
2017
|
| Subjects: | |
| Online Access: | http://www.teses.usp.br/teses/disponiveis/9/9139/tde-06122017-100536/ |